Literature DB >> 25377730

Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.

Christine M Emnett1, Lawrence N Eisenman, Jayaram Mohan, Amanda A Taylor, James J Doherty, Steven M Paul, Charles F Zorumski, Steven Mennerick.   

Abstract

BACKGROUND AND
PURPOSE: Memantine and ketamine are clinically used, open-channel blockers of NMDA receptors exhibiting remarkable pharmacodynamic similarities despite strikingly different clinical profiles. Although NMDA channel gating constitutes an important difference between memantine and ketamine, it is unclear how positive allosteric modulators (PAMs) might affect the pharmacodynamics of these NMDA blockers. EXPERIMENTAL APPROACH: We used two different PAMs: SGE-201, an analogue of an endogenous oxysterol, 24S-hydroxycholesterol, along with pregnenolone sulphate (PS), to test on memantine and ketamine responses in single cells (oocytes and cultured neurons) and networks (hippocampal slices), using standard electrophysiological techniques. KEY
RESULTS: SGE-201 and PS had no effect on steady-state block or voltage dependence of a channel blocker. However, both PAMs increased the actions of memantine and ketamine on phasic excitatory post-synaptic currents, but neither revealed underlying pharmacodynamic differences. SGE-201 accelerated the re-equilibration of blockers during voltage jumps. SGE-201 also unmasked differences among the blockers in neuronal networks - measured either by suppression of activity in multi-electrode arrays or by neuroprotection against a mild excitotoxic insult. Either potentiating NMDA receptors while maintaining the basal activity level or increasing activity/depolarization without potentiating NMDA receptor function is sufficient to expose pharmacodynamic blocker differences in suppressing network function and in neuroprotection. CONCLUSIONS AND IMPLICATIONS: Positive modulation revealed no pharmacodynamic differences between NMDA receptor blockers at a constant voltage, but did expose differences during spontaneous network activity. Endogenous modulator tone of NMDA receptors in different brain regions may underlie differences in the effects of NMDA receptor blockers on behaviour.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25377730      PMCID: PMC4337705          DOI: 10.1111/bph.13007

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  59 in total

1.  Genome-wide atlas of gene expression in the adult mouse brain.

Authors:  Ed S Lein; Michael J Hawrylycz; Nancy Ao; Mikael Ayres; Amy Bensinger; Amy Bernard; Andrew F Boe; Mark S Boguski; Kevin S Brockway; Emi J Byrnes; Lin Chen; Li Chen; Tsuey-Ming Chen; Mei Chi Chin; Jimmy Chong; Brian E Crook; Aneta Czaplinska; Chinh N Dang; Suvro Datta; Nick R Dee; Aimee L Desaki; Tsega Desta; Ellen Diep; Tim A Dolbeare; Matthew J Donelan; Hong-Wei Dong; Jennifer G Dougherty; Ben J Duncan; Amanda J Ebbert; Gregor Eichele; Lili K Estin; Casey Faber; Benjamin A Facer; Rick Fields; Shanna R Fischer; Tim P Fliss; Cliff Frensley; Sabrina N Gates; Katie J Glattfelder; Kevin R Halverson; Matthew R Hart; John G Hohmann; Maureen P Howell; Darren P Jeung; Rebecca A Johnson; Patrick T Karr; Reena Kawal; Jolene M Kidney; Rachel H Knapik; Chihchau L Kuan; James H Lake; Annabel R Laramee; Kirk D Larsen; Christopher Lau; Tracy A Lemon; Agnes J Liang; Ying Liu; Lon T Luong; Jesse Michaels; Judith J Morgan; Rebecca J Morgan; Marty T Mortrud; Nerick F Mosqueda; Lydia L Ng; Randy Ng; Geralyn J Orta; Caroline C Overly; Tu H Pak; Sheana E Parry; Sayan D Pathak; Owen C Pearson; Ralph B Puchalski; Zackery L Riley; Hannah R Rockett; Stephen A Rowland; Joshua J Royall; Marcos J Ruiz; Nadia R Sarno; Katherine Schaffnit; Nadiya V Shapovalova; Taz Sivisay; Clifford R Slaughterbeck; Simon C Smith; Kimberly A Smith; Bryan I Smith; Andy J Sodt; Nick N Stewart; Kenda-Ruth Stumpf; Susan M Sunkin; Madhavi Sutram; Angelene Tam; Carey D Teemer; Christina Thaller; Carol L Thompson; Lee R Varnam; Axel Visel; Ray M Whitlock; Paul E Wohnoutka; Crissa K Wolkey; Victoria Y Wong; Matthew Wood; Murat B Yaylaoglu; Rob C Young; Brian L Youngstrom; Xu Feng Yuan; Bin Zhang; Theresa A Zwingman; Allan R Jones
Journal:  Nature       Date:  2006-12-06       Impact factor: 49.962

2.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

3.  Synaptic NMDA receptor channels have a low open probability.

Authors:  C Rosenmund; A Feltz; G L Westbrook
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

4.  Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents.

Authors:  K A Yamada; C M Tang
Journal:  J Neurosci       Date:  1993-09       Impact factor: 6.167

Review 5.  Ketamine: use in anesthesia.

Authors:  Susan Marland; John Ellerton; Gary Andolfatto; Giacomo Strapazzon; Oyvind Thomassen; Brigitta Brandner; Andrew Weatherall; Peter Paal
Journal:  CNS Neurosci Ther       Date:  2013-03-22       Impact factor: 5.243

6.  Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats.

Authors:  Shawn E Kotermanski; Jon W Johnson; Edda Thiels
Journal:  Pharmacol Biochem Behav       Date:  2013-05-08       Impact factor: 3.533

7.  Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain.

Authors:  Denise M O Ramirez; Stefan Andersson; David W Russell
Journal:  J Comp Neurol       Date:  2008-04-10       Impact factor: 3.215

8.  Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols.

Authors:  Kersti Karu; Martin Hornshaw; Gary Woffendin; Karl Bodin; Mats Hamberg; Gunvor Alvelius; Jan Sjövall; John Turton; Yuqin Wang; William J Griffiths
Journal:  J Lipid Res       Date:  2007-01-24       Impact factor: 5.922

9.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

10.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

View more
  18 in total

1.  Quantification of bursting and synchrony in cultured hippocampal neurons.

Authors:  Lawrence N Eisenman; Christine M Emnett; Jayaram Mohan; Charles F Zorumski; Steven Mennerick
Journal:  J Neurophysiol       Date:  2015-06-03       Impact factor: 2.714

2.  Ketamine: NMDA Receptors and Beyond.

Authors:  Charles F Zorumski; Yukitoshi Izumi; Steven Mennerick
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

Review 3.  24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.

Authors:  Min-Yu Sun; Andrew J Linsenbardt; Christine M Emnett; Lawrence N Eisenman; Yukitoshi Izumi; Charles F Zorumski; Steve Mennerick
Journal:  Neuroscientist       Date:  2015-01-27       Impact factor: 7.519

4.  The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models.

Authors:  Elizaveta Khlestova; Jon W Johnson; John H Krystal; John Lisman
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

5.  In vitro cytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds.

Authors:  Natalia Mast; Kyle W Anderson; Kevin M Johnson; Thanh T N Phan; F Peter Guengerich; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2017-06-22       Impact factor: 5.157

6.  Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices.

Authors:  Min-Yu Sun; Yukitoshi Izumi; Ann Benz; Charles F Zorumski; Steven Mennerick
Journal:  J Neurophysiol       Date:  2015-12-23       Impact factor: 2.714

7.  Comparison of Steroid Modulation of Spontaneous Inhibitory Postsynaptic Currents in Cultured Hippocampal Neurons and Steady-State Single-Channel Currents from Heterologously Expressed α1β2γ2L GABA(A) Receptors.

Authors:  Sampurna Chakrabarti; Mingxing Qian; Kathiresan Krishnan; Douglas F Covey; Steven Mennerick; Gustav Akk
Journal:  Mol Pharmacol       Date:  2016-01-14       Impact factor: 4.436

8.  Visualizing pregnenolone sulfate-like modulators of NMDA receptor function reveals intracellular and plasma-membrane localization.

Authors:  Mariangela Chisari; Timothy J Wilding; Samuel Brunwasser; Kathiresan Krishnan; Mingxing Qian; Ann Benz; James E Huettner; Charles F Zorumski; Douglas F Covey; Steven Mennerick
Journal:  Neuropharmacology       Date:  2018-10-15       Impact factor: 5.250

9.  Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.

Authors:  Xiaofei Wei; Toshiya Nishi; Shinichi Kondou; Haruhide Kimura; Istvan Mody
Journal:  Neuropharmacology       Date:  2018-12-27       Impact factor: 5.250

10.  Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.

Authors:  Natasha Warikoo; Samuel J Brunwasser; Ann Benz; Hong-Jin Shu; Steven M Paul; Michael Lewis; James Doherty; Michael Quirk; Laura Piccio; Charles F Zorumski; Gregory S Day; Steven Mennerick
Journal:  J Neurosci       Date:  2018-02-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.